Chlorambucil

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
220pxpx }}
Chlorambucil
Systematic (IUPAC) name
4-[bis(2-chlorethyl)amino]benzenebutanoic acid
Identifiers
CAS number 305-03-3
ATC code L01AA02
PubChem 2708
DrugBank APRD00115
Chemical data
Formula C14H19Cl2NO2 
Mol. mass 304.212 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism Hepatic
Half life 1.5 hours
Excretion N/A
Therapeutic considerations
Pregnancy cat.

D(US)

Legal status

Prescription only

Routes Oral

WikiDoc Resources for

Chlorambucil

Articles

Most recent articles on Chlorambucil

Most cited articles on Chlorambucil

Review articles on Chlorambucil

Articles on Chlorambucil in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Chlorambucil

Images of Chlorambucil

Photos of Chlorambucil

Podcasts & MP3s on Chlorambucil

Videos on Chlorambucil

Evidence Based Medicine

Cochrane Collaboration on Chlorambucil

Bandolier on Chlorambucil

TRIP on Chlorambucil

Clinical Trials

Ongoing Trials on Chlorambucil at Clinical Trials.gov

Trial results on Chlorambucil

Clinical Trials on Chlorambucil at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Chlorambucil

NICE Guidance on Chlorambucil

NHS PRODIGY Guidance

FDA on Chlorambucil

CDC on Chlorambucil

Books

Books on Chlorambucil

News

Chlorambucil in the news

Be alerted to news on Chlorambucil

News trends on Chlorambucil

Commentary

Blogs on Chlorambucil

Definitions

Definitions of Chlorambucil

Patient Resources / Community

Patient resources on Chlorambucil

Discussion groups on Chlorambucil

Patient Handouts on Chlorambucil

Directions to Hospitals Treating Chlorambucil

Risk calculators and risk factors for Chlorambucil

Healthcare Provider Resources

Symptoms of Chlorambucil

Causes & Risk Factors for Chlorambucil

Diagnostic studies for Chlorambucil

Treatment of Chlorambucil

Continuing Medical Education (CME)

CME Programs on Chlorambucil

International

Chlorambucil en Espanol

Chlorambucil en Francais

Businness

Chlorambucil in the Marketplace

Patents on Chlorambucil

Experimental / Informatics

List of terms related to Chlorambucil

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

For patient information, click here

Overview

Chlorambucil (marketed as Leukeran by GlaxoSmithKline) is a chemotherapy drug that has been mainly used in the treatment of chronic lymphocytic leukemia. It is a nitrogen mustard alkylating agent and can be given orally.

In the past, it has been used for treating some types of non-Hodgkin lymphoma, Waldenström macroglobulinemia, polycythemia vera, trophoblastic neoplasms, ovarian carcinoma. It also has been used as an immunosuppressive drug for various autoimmune and inflammatory conditions, e.g. nephrotic syndrome. Its current use is mainly for CLL as it is well tolerated by most patients, though this has been primarily replaced by fludarabine.[1]

Side Effects

The IARC has found strong evidence that chlorambucil is itself a cancer agent, and listed it as such in its list 1.

Myelosuppression (anemia, neutropenia, thrombocytopenia), or bone marrow suppression is the most commonly occurring side effect of chlorambucil. Withdrawn from the drug, this side effect may be reversible, but bone marrow failure can occur in rare cases.

Less commonly occurring side effects include:

References

External links


de:Chlorambucil
WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
In other languages